淋巴结比率是喉和下支状细胞癌的预后因素
Justin M Hintze1, Eoin Cleere1, Conrad Timon2
1Department of Otolaryngology - Head and Neck Surgery, St. James' Hospital, Dublin, Ireland; Royal College of Surgeons, Ireland; University of Dublin, Trinity College, Dublin, Ireland.
Oral oncology
|August 28, 2025
概括
淋巴结比率大于0.05是头癌患者病情恶化的重要预测因素. 然而,更高的淋巴结产量与无复发生存率的改善有关.
科学领域:
- 癌症学
- 外科病理学
背景情况:
- 淋巴结产量和淋巴结比率是头癌的关键预后指标.
- 这些指标反映了疾病负担和护理质量标准.
研究的目的:
- 研究不同淋巴结产量截止值和淋巴结比对长期结果的影响.
- 分析10年无复发间隔和喉和下癌患者的整体存活率.
主要方法:
- 一项为期10年的单中心队列研究 (2013-2023) 涉及157名患者.
- 患者接受了喉切除术或喉切除术,以治疗状细胞癌.
- 数据包括病理因素,手术特征,边际状态,复发和存活率.
主要成果:
- 淋巴结比率>0. 05和额外节点延伸是无复发和整体存活率较差的独立预测因素.
- 更高的淋巴结产量 (> 18 和 > 26 个结) 与改善的无复发间隔相关.
- 挽救手术也被认为是一种负面预后.
结论:
- 淋巴结比> 0. 05 是晚期喉和下癌的生存的一个独立不良预后因素.
- 这些发现支持将节点指标纳入这些癌症的风险分层.
- 这项研究强调了节点状况在预测患者结果方面的重要性.
相关概念视频
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...


